BR0315895A - Conjugados iÈnicos poliméricos sólidos e semi-sólidos, composição farmacêutica, processo para preparação dos referidos conjugados e composição sólida ou semi-sólida - Google Patents
Conjugados iÈnicos poliméricos sólidos e semi-sólidos, composição farmacêutica, processo para preparação dos referidos conjugados e composição sólida ou semi-sólidaInfo
- Publication number
- BR0315895A BR0315895A BR0315895-0A BR0315895A BR0315895A BR 0315895 A BR0315895 A BR 0315895A BR 0315895 A BR0315895 A BR 0315895A BR 0315895 A BR0315895 A BR 0315895A
- Authority
- BR
- Brazil
- Prior art keywords
- solid
- semi
- conjugates
- composition
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
"CONJUGADOS IÈNICOS POLIMéRICOS SóLIDOS E SEMI-SóLIDOS, COMPOSIçãO FARMACêUTICA, PROCESSO PARA PREPARAçãO DOS REFERIDOS CONJUGADOS E COMPOSIçãO SóLIDA OU SEMI-SóLIDA". A presente invenção refere-se à solubilidade aquosa de drogas tais como ziprasidona que é melhorada usando um polímero funcional para formar um conjugado iónico com a referida droga.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42283202P | 2002-10-31 | 2002-10-31 | |
PCT/IB2003/004699 WO2004039411A2 (en) | 2002-10-31 | 2003-10-24 | Solid and semi-solid polymeric ionic conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0315895A true BR0315895A (pt) | 2005-10-04 |
Family
ID=32230392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0315895-0A BR0315895A (pt) | 2002-10-31 | 2003-10-24 | Conjugados iÈnicos poliméricos sólidos e semi-sólidos, composição farmacêutica, processo para preparação dos referidos conjugados e composição sólida ou semi-sólida |
Country Status (8)
Country | Link |
---|---|
US (2) | US20040142039A1 (pt) |
EP (1) | EP1556086A2 (pt) |
JP (1) | JP2006506397A (pt) |
AU (1) | AU2003272011A1 (pt) |
BR (1) | BR0315895A (pt) |
CA (1) | CA2499132A1 (pt) |
MX (1) | MXPA05004721A (pt) |
WO (1) | WO2004039411A2 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1744750A2 (en) | 2004-05-06 | 2007-01-24 | Sandoz AG | Pharmaceutical composition comprising hydrophobic drug having improved solubility |
WO2006000913A1 (en) * | 2004-06-23 | 2006-01-05 | Pfizer Products Inc. | Method for sterile filtration of viscous pharmaceutical compositions |
US8840876B2 (en) * | 2005-05-19 | 2014-09-23 | Ethicon, Inc. | Antimicrobial polymer compositions and the use thereof |
US20090099319A1 (en) * | 2006-04-28 | 2009-04-16 | Basf Se | Method for solubilising hydrophobic active substances in an aqueous medium |
WO2008109483A1 (en) * | 2007-03-02 | 2008-09-12 | The Board Of Trustees Of The University Of Illinois | Particulate drug delivery |
US20130108701A1 (en) | 2010-05-25 | 2013-05-02 | Krishna Murthy Bhavanasi | Solid Dosage Forms of Antipsychotics |
JP5989126B2 (ja) * | 2011-10-17 | 2016-09-07 | ポリ−メド インコーポレイテッド | 吸収性現場ゲル形成システム、その製造方法及びその使用 |
JP6154163B2 (ja) * | 2013-03-15 | 2017-06-28 | 独立行政法人国立高等専門学校機構 | 水不溶性シクロデキストリンポリマーおよびその製造方法 |
CN114414612B (zh) * | 2022-01-28 | 2023-06-20 | 浙江大学 | 一种聚乙烯管材专用料耐压等级快速预判方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3418329A (en) * | 1965-10-24 | 1968-12-24 | Upjohn Co | p-amino-n-(3- or 5-methyl-2 pyridyl) benzamide and the pharmaceutically acceptable acid addition salts thereof |
HU220137B (hu) * | 1993-01-06 | 2001-11-28 | Kinerton Ltd. | Biológiailag lebontható poliészterek és biológiailag aktív polipeptidek ionos molekuláris konjugátumai, eljárás ezek előállítására és eljárás mikrorészecskék előállítására |
US6221958B1 (en) * | 1993-01-06 | 2001-04-24 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
UA57734C2 (uk) * | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
US5916883A (en) * | 1996-11-01 | 1999-06-29 | Poly-Med, Inc. | Acylated cyclodextrin derivatives |
GB9718986D0 (en) * | 1997-09-09 | 1997-11-12 | Danbiosyst Uk | Controlled release microsphere delivery system |
US7018645B1 (en) * | 2000-04-27 | 2006-03-28 | Macromed, Inc. | Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties |
US6589549B2 (en) * | 2000-04-27 | 2003-07-08 | Macromed, Incorporated | Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
EP1269994A3 (en) * | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
-
2003
- 2003-10-24 US US10/693,383 patent/US20040142039A1/en not_active Abandoned
- 2003-10-24 EP EP03753852A patent/EP1556086A2/en not_active Withdrawn
- 2003-10-24 AU AU2003272011A patent/AU2003272011A1/en not_active Abandoned
- 2003-10-24 BR BR0315895-0A patent/BR0315895A/pt not_active IP Right Cessation
- 2003-10-24 MX MXPA05004721A patent/MXPA05004721A/es unknown
- 2003-10-24 CA CA002499132A patent/CA2499132A1/en not_active Abandoned
- 2003-10-24 WO PCT/IB2003/004699 patent/WO2004039411A2/en not_active Application Discontinuation
- 2003-10-24 JP JP2004547898A patent/JP2006506397A/ja active Pending
-
2009
- 2009-06-17 US US12/486,414 patent/US20090257975A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA05004721A (es) | 2005-08-03 |
WO2004039411A3 (en) | 2004-07-22 |
CA2499132A1 (en) | 2004-05-13 |
US20040142039A1 (en) | 2004-07-22 |
EP1556086A2 (en) | 2005-07-27 |
AU2003272011A1 (en) | 2004-05-25 |
US20090257975A1 (en) | 2009-10-15 |
WO2004039411A2 (en) | 2004-05-13 |
AU2003272011A8 (en) | 2004-05-25 |
JP2006506397A (ja) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0412671A (pt) | conjugados de um polìmero e uma proteìna ligados por um grupo de ligação de oxima | |
AR025444A1 (es) | Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos | |
BR0102040A (pt) | Uso de paclitaxel estabilizado com albumina para preparação de uma droga para o tratamento de tumores sólidos e a droga desse modo obtida | |
BRPI0407504A (pt) | heterociclos n-arila substituìdo, processo para sua preparação e uso dos mesmos como medicamentos | |
BR0112589A (pt) | Derivados de heteroarila e sua aplicação como medicamento | |
WO2004082628A3 (en) | Improved bioavailability and improved delivery of acidic pharmaceutical drugs | |
CR7171A (es) | Composiciones farmaceuticas de farmacos y polimeros acidos neutralizados | |
BRPI0613005A8 (pt) | uso de polipeptídeos de aprotinina como veículos em conjugados farmacêuticos. | |
BR0112591A (pt) | Derivados de acridina e sua aplicação como medicamento | |
BR0211601A (pt) | Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos | |
BR0214342A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
BRPI0417341A (pt) | fator ix glicopeguilado | |
BRPI0607549A2 (pt) | sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos | |
SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
BR0208338A (pt) | Derivados de piridina | |
BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
WO2000064486A3 (en) | Enzymatically activated polymeric drug conjugates | |
BR0116607A (pt) | Derivados de glicopiranosiloxipirazol e uso dos mesmos em medicamentos | |
BR0210139A (pt) | Composições farmacêuticas | |
BR0315895A (pt) | Conjugados iÈnicos poliméricos sólidos e semi-sólidos, composição farmacêutica, processo para preparação dos referidos conjugados e composição sólida ou semi-sólida | |
BRPI0607614A2 (pt) | sal de besilato da 7-(2-(4-3-trifluorometil-fenil)-1,2,3,6-tetrahidropirid- 1-il)etil) isoquinoleìna, o respectivo medicamento, composição farmacêutica e uso | |
BR0313428A (pt) | Composições farmacêuticas de drogas semi-ordenados e polìmeros | |
BR0208468A (pt) | Camsilato de amlodipina e processo para sua preparação | |
BR0008297A (pt) | Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma | |
BR0112807A (pt) | Derivados de indol e sua aplicação como medicamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 47/59 (2017.01), A61K 47/60 (2017.01) |